SE452465B - 6 beta-halopenicillansyraderivat och kompositioner innehallande desamma - Google Patents

6 beta-halopenicillansyraderivat och kompositioner innehallande desamma

Info

Publication number
SE452465B
SE452465B SE8003722A SE8003722A SE452465B SE 452465 B SE452465 B SE 452465B SE 8003722 A SE8003722 A SE 8003722A SE 8003722 A SE8003722 A SE 8003722A SE 452465 B SE452465 B SE 452465B
Authority
SE
Sweden
Prior art keywords
salt
acid
compound according
solution
water
Prior art date
Application number
SE8003722A
Other languages
English (en)
Swedish (sv)
Other versions
SE8003722L (sv
Inventor
Daehne W Von
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SE8003722L publication Critical patent/SE8003722L/xx
Publication of SE452465B publication Critical patent/SE452465B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8003722A 1979-05-21 1980-05-19 6 beta-halopenicillansyraderivat och kompositioner innehallande desamma SE452465B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7917665 1979-05-21
GB7930819 1979-09-05
GB7941252 1979-11-29
GB8006681 1980-02-27

Publications (2)

Publication Number Publication Date
SE8003722L SE8003722L (sv) 1980-11-22
SE452465B true SE452465B (sv) 1987-11-30

Family

ID=27449123

Family Applications (3)

Application Number Title Priority Date Filing Date
SE8003722A SE452465B (sv) 1979-05-21 1980-05-19 6 beta-halopenicillansyraderivat och kompositioner innehallande desamma
SE8406202A SE462097B (sv) 1979-05-21 1984-12-06 Foerfarande foer framstaellning av en i huvudsak ren 6 beta-halogen penicillansyra
SE8406201A SE462096B (sv) 1979-05-21 1984-12-06 Dicyklohexylammonium-6 beta-brompenicillanat vilken aer anvaendbar saasom mellanprodukt

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8406202A SE462097B (sv) 1979-05-21 1984-12-06 Foerfarande foer framstaellning av en i huvudsak ren 6 beta-halogen penicillansyra
SE8406201A SE462096B (sv) 1979-05-21 1984-12-06 Dicyklohexylammonium-6 beta-brompenicillanat vilken aer anvaendbar saasom mellanprodukt

Country Status (19)

Country Link
US (3) US4446144A (xx)
JP (1) JPS55154977A (xx)
AU (3) AU534754B2 (xx)
BE (1) BE883390A (xx)
CA (1) CA1265787A (xx)
DE (3) DE3051038C2 (xx)
DK (2) DK158669C (xx)
FI (1) FI801618A (xx)
FR (2) FR2457294A1 (xx)
GR (1) GR68372B (xx)
IE (2) IE49768B1 (xx)
IL (1) IL59948A0 (xx)
IT (1) IT1133091B (xx)
LU (1) LU82468A1 (xx)
NL (1) NL8002911A (xx)
NZ (1) NZ193597A (xx)
PH (2) PH17959A (xx)
PT (1) PT71273A (xx)
SE (3) SE452465B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
US4521533A (en) * 1984-07-12 1985-06-04 Pfizer Inc. Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics
GB8522156D0 (en) * 1985-09-06 1985-10-09 Leo Pharm Prod Ltd Producing chemical compounds
US5695951A (en) * 1994-12-20 1997-12-09 Biopure Corporation Chlorination of cephalexin with chloroperoxidase from Rathayibacter biopuresis
US5589354A (en) * 1994-12-20 1996-12-31 Biopure Corporation Halogenation of cephalexin with haloperoxidase from Rathayibacter biopuresis
CA2274796C (en) 1996-12-18 2006-12-05 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
JP4584715B2 (ja) * 2002-10-25 2010-11-24 インターベツト・インターナシヨナル・ベー・ベー 持続放出性医薬組成物
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004025324A1 (de) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
EP2874623B1 (en) 2012-07-17 2018-12-12 Bayer New Zealand Limited Injectable antibiotic formulations and their methods of use
PL2874624T3 (pl) * 2012-07-17 2020-07-27 Bayer New Zealand Limited 3 Argus Place Hillcrest, Auckland 0627 / NZ Wstrzykiwalne formulacje antybiotykowe i sposoby ich zastosowania
WO2014098624A1 (en) * 2012-12-20 2014-06-26 Alleva Animal Health Limited Veterinary injectable formulations
EP4265241A1 (en) * 2022-04-20 2023-10-25 Bilim Ilac Sanayii Ve Ticaret A.S. Tablet formulations for the treatment of urinary system infections and method for the preparation of such formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089385B (de) 1954-06-21 1960-09-22 Biochemie Gmbh Verfahren zur Herstellung von in Wasser schwer loeslichen, besonders fuer die Oraltherapie geeigneten Salzen des Penicillins mit organischen Basen
DE1031795B (de) 1955-09-29 1958-06-12 Chimiotherapie Lab Franc Verfahren zur Herstellung eines Salzes aus Penicillin und einer Piperazinbase
US3206469A (en) * 1961-08-15 1965-09-14 Lepetit Spa 6-halopenicillanic acid
GB1297555A (xx) * 1970-09-22 1972-11-22
GB1377817A (en) * 1971-06-09 1974-12-18 Beecham Group Ltd Penicillins and cephalosporins
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
IN149747B (xx) * 1977-06-07 1982-04-03 Pfizer
US4180506A (en) * 1978-01-18 1979-12-25 Rex Pratt 6β-Bromo penicillanic acid
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
US4203992A (en) * 1978-12-11 1980-05-20 E. R. Squibb & Sons, Inc. β-Bromopenicillanic acid sulfone
DE3068390D1 (en) * 1979-01-10 1984-08-09 Beecham Group Plc Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them
US4397783A (en) * 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
US4518530A (en) * 1979-03-05 1985-05-21 Pfizer Inc. 6-β-Substituted penicillanic acids as β-lactamase inhibitors
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors

Also Published As

Publication number Publication date
LU82468A1 (fr) 1980-12-16
CA1265787A (en) 1990-02-13
DK158669B (da) 1990-07-02
GR68372B (xx) 1981-12-28
FR2457294B1 (xx) 1984-01-13
DK562589D0 (da) 1989-11-10
FR2499575B1 (xx) 1985-03-01
DK218580A (da) 1980-11-22
FI801618A (fi) 1980-11-22
IE49768B1 (en) 1985-12-11
SE8406202D0 (sv) 1984-12-06
IL59948A0 (en) 1980-06-30
FR2457294A1 (fr) 1980-12-19
DE3051038A1 (xx) 1986-03-20
AU1848783A (en) 1983-12-22
IT1133091B (it) 1986-07-09
DE3019244A1 (de) 1980-12-04
PT71273A (en) 1980-06-01
PH17959A (en) 1985-02-20
AU541323B2 (en) 1985-01-03
DE3051037C2 (xx) 1989-03-30
JPS55154977A (en) 1980-12-02
IE49770B1 (en) 1985-12-11
SE8406201L (sv) 1984-12-06
US4594246A (en) 1986-06-10
IE842559L (en) 1980-11-21
BE883390A (fr) 1980-11-20
FR2499575A1 (fr) 1982-08-13
US4672114A (en) 1987-06-09
DE3019244C2 (xx) 1989-04-06
AU541322B2 (en) 1985-01-03
SE8406201D0 (sv) 1984-12-06
JPH0140837B2 (xx) 1989-08-31
DK158669C (da) 1991-01-21
IT8067790A0 (it) 1980-05-20
DK158670C (da) 1991-01-07
DK562589A (da) 1989-11-10
AU534754B2 (en) 1984-02-16
PH19005A (en) 1985-12-03
DE3051038C2 (xx) 1989-04-13
NZ193597A (en) 1985-04-30
NL8002911A (nl) 1980-11-25
SE462096B (sv) 1990-05-07
SE8003722L (sv) 1980-11-22
SE462097B (sv) 1990-05-07
IE800868L (en) 1980-11-21
US4446144A (en) 1984-05-01
AU1848683A (en) 1983-12-22
AU5858480A (en) 1980-11-27
SE8406202L (sv) 1984-12-06
DK158670B (da) 1990-07-02

Similar Documents

Publication Publication Date Title
KR100245938B1 (ko) 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 결정성 수화물 및 이들의 제조방법
SE452465B (sv) 6 beta-halopenicillansyraderivat och kompositioner innehallande desamma
DE3005164A1 (de) Antibiotisch wirksame beta -lactamverbindungen, verfahren zu deren herstellung und sie enthaltendes arzneimittel
DE1795292B2 (de) Cephalosporinderivate und Verfahren zu deren Herstellung
DE2356388A1 (de) Cephalosporine und verfahren zu ihrer herstellung
EP0004956B1 (de) Beta-Lactamantibiotika, Verfahren zu ihrer Herstellung, Futterzusatzmittel, Arzneimittel sowie Verfahren zu deren Herstellung
DE2446901A1 (de) 7-acetoacetamidocephemverbindungen, verfahren zur herstellung derselben und diese enthaltende pharmazeutische mittel
DE2539411A1 (de) Cephamycine, ihre salze, verfahren zu ihrer herstellung und arzneipraeparate
DE3506159A1 (de) Neue cephalosporine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3419013A1 (de) Neue cephalosporine und verfahren zu ihrer herstellung
FR2517309A1 (fr) Nouveaux derives de cephalosporines substitues en position 3 par un groupe heterocycle thiomethyl; procede de preparation desdits composes et compositions pharmaceutiques en contenant
FR2553418A1 (fr) Derives d'acides (oxo carbonamido heterocyclique) cephem carboxyliques a proprietes antibacteriennes
JPS5931796A (ja) Ｄｍｔのｃ−２３−修飾誘導体
EP0223184A2 (de) Neue Cephalosporine, Verfahren zu deren Herstellung sowie ihre Verwendung als Arzneimittel
GB2051046A (en) Penicillanic acid derivatives
US4511512A (en) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
EP0101933A1 (de) 4H-1,4-Benzothiazin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel, Futterzusatzstoffe und Konservierungsmittel
EP0098433A2 (de) Beta-Lactamantibiotika, Verfahren zu deren Herstellung sowie sie enthaltende Mittel
JPS5852291A (ja) ペニシリン系抗生物質誘導体とその医薬剤
JPH0414679B2 (xx)
GB2125038A (en) Amine salts of 6 beta -halopenicillanic acids
IL21947A (en) 6-alpha-amino acetamino-thiopenicillanic acid
DE2700178A1 (de) Verfahren zur herstellung von 1,3-disubstituiertem-2-acetidinon
IE49769B1 (en) Amine salts of 6beta-halopenicillanic acids
DE3127488A1 (de) 1,3-thiazolidin-4-yl-carbonsaeure-derivate, verfahrenzu ihrer herstellung und sie enthaltende mittel fuer die verwendung in der human- oder veterinaermedizin oder in der landwirtschaft

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8003722-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8003722-9

Format of ref document f/p: F